Innovus Pharmaceuticals Inc (OTCMKTS:INNVD – Get Rating) rose 143.9% during mid-day trading on Tuesday . The company traded as high as $3.49 and last traded at $3.00. Approximately 4,300 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 9,592 shares. The stock had previously closed at $1.23.
Innovus Pharmaceuticals Price Performance
The company has a market cap of $7.07 million, a P/E ratio of -0.72 and a beta of 2.89. The stock’s fifty day simple moving average is $3.00.
Innovus Pharmaceuticals Company Profile
Innovus Pharmaceuticals, Inc, a pharmaceutical company, engages in the development, licensing, and commercialization of non-prescription medicines and consumer care products in the United States. Its products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream for penile sensitivity; Zestra Glide, a water-based longer lasting lubricant; Vesele, a proprietary oral supplement for promoting sexual health; and Androferti, a natural supplement to support male reproductive health and sperm quality.
- Get a free copy of the StockNews.com research report on Innovus Pharmaceuticals (INNVD)
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Innovus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.